-+ 0.00%
-+ 0.00%
-+ 0.00%

*Macrogenics: Ending Development of Lorigerlimab in Prostate Cancer While Continuing Development in Ovarian Cancer >MGNX

Dow Jones·11/12/2025 21:13:00

Please log in to view news